Cutaneous adverse reactions to anti-PD-1 treatment-A systematic review

被引：31

作者：

Simonsen, Anne Birgitte ^{[1
]}

Kaae, Jeanette ^{[1
]}

Ellebaek, Eva ^{[2
]}

Svane, Inge Marie ^{[2
]}

Zachariae, Claus ^{[1
]}

机构：

[1] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Copenhagen, Denmark

[2] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Oncol, Copenhagen, Denmark

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 83卷 / 05期

关键词：

anti-PD-1; cutaneous adverse reaction; dermatology; immunotherapy; oncology; IMMUNE CHECKPOINT BLOCKADE; STEVENS-JOHNSON SYNDROME; PROGRAMMED CELL DEATH-1; METASTATIC MELANOMA; NIVOLUMAB THERAPY; LICHEN-PLANUS; PEMBROLIZUMAB THERAPY; LUNG-CANCER; PSORIASIFORM ERUPTION; DRUG ERUPTION;

D O I：

10.1016/j.jaad.2020.04.058

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

The use of the humanized monoclonal anti-programmed cell death 1 antibodies pembrolizumab and nivolumab as potent anticancer therapies is rapidly increasing. However, since their approval, numerous cases of cutaneous reactions have been reported. Cutaneous adverse reactions to these agents have yet to be fully characterized and range from nonspecific eruptions to recognizable skin manifestations, which may be localized and vary from mild to life threatening. This systematic review article provides an overview of the various adverse cutaneous reactions to pembrolizumab and nivolumab therapy and offers suggestions for their management.

引用

页码：1415 / 1424

页数：10

共 133 条

[1] Bullous Pemphigoid-like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature [J].

Anastasopoulou, Amalia ;

Papaxoinis, Georgios ;

Diamantopoulos, Panagiotis ;

Christofidou, Erietta ;

Benopoulou, Olga ;

Stratigos, Alexandros ;

Gogas, Helen .

JOURNAL OF IMMUNOTHERAPY, 2018, 41 (03) :164-167

[2] GUIDELINES FOR THE TREATMENT OF VITILIGO [J].

ANTONIOU, C ;

KATSAMBAS, A .

DRUGS, 1992, 43 (04) :490-498

[3] Scleroderma Induced by Pembrolizumab: A Case Series [J].

Barbosa, Naiara S. ;

Wetter, David A. ;

Wieland, Carilyn N. ;

Shenoy, Niraj K. ;

Markovic, Svetomir N. ;

Thanarajasingam, Uma .

MAYO CLINIC PROCEEDINGS, 2017, 92 (07) :1158-1163

[4] Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid [J].

Beck, Kristen M. ;

Dong, Joanna ;

Geskin, Larisa J. ;

Beltrani, Vincent P. ;

Phelps, Richard G. ;

Carvajal, Richard D. ;

Schwartz, Gary ;

Saenger, Yvonne M. ;

Gartrell, Robyn D. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4

[5] Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor [J].

Belum, V. R. ;

Benhuri, B. ;

Postow, M. A. ;

Hellmann, M. D. ;

Lesokhin, A. M. ;

Segal, N. H. ;

Motzer, R. J. ;

Wu, S. ;

Busam, K. J. ;

Wolchok, J. D. ;

Lacouture, M. E. .

EUROPEAN JOURNAL OF CANCER, 2016, 60 :12-25

[6] A Severe, Refractory Case of Mucous Membrane Pemphigoid After Treatment With Pembrolizumab: Brief Communication [J].

Bezinelli, Leticia Mello ;

Eduardo, Fernanda P. ;

Migliorati, Cesar A. ;

Ferreira, Mariana H. ;

Taranto, Patricia ;

Sales, Diogo B. ;

Santi, Claudia G. ;

Macarenco, Ricardo S. ;

Godoy, Claudia P., V ;

Correa, Luciana ;

Buzaid, Antonio C. .

JOURNAL OF IMMUNOTHERAPY, 2019, 42 (09) :359-362

[7] Linear bullous lichen planus associated with nivolumab [J].

Biolo, G. ;

Caroppo, F. ;

Salmaso, R. ;

Alaibac, M. .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (01) :67-68

[8]

Birnbaum Mathew R, 2017, JAAD Case Rep, V3, P208, DOI 10.1016/j.jdcr.2017.02.015

[9] Cutaneous lupus associated with pembrolizumab therapy for advanced melanoma: a report of three cases [J].

Blakeway, Elizabeth A. ;

Elshimy, Noha ;

Muinonen-Martin, Andrew ;

Marples, Maria ;

Mathew, Bipin ;

Mitra, Angana .

MELANOMA RESEARCH, 2019, 29 (03) :338-341

[10] Cutaneous toxicities of new treatments for melanoma [J].

Boada, A. ;

Carrera, C. ;

Segura, S. ;

Collgros, H. ;

Pasquali, P. ;

Bodet, D. ;

Puig, S. ;

Malvehy, J. .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (11) :1373-1384

← 1 2 3 4 5 6 7 8 9 10 →